High and low doses with increased IMT, moderate (0.15–0.4 mg/kg/day) doses with decreased IMT in children [26] and adults [27] IMT: Intima-media thickness; SLE: Systemic lupus erythematosus.

Background SLE is a systemic autoimmune disease with a large number of common risk gene variants, but several rare gene ...

Systemic lupus erythematosus (SLE), also known as lupus, is an autoimmune disease that happens when the body’s defence system, which is supposed to help our body fight infections, turns against ...

Objective Disease activity both between and within patients with SLE is highly variable, yet factors driving this variability remain unclear. This study aimed to identify predictors of variability in ...

Autoimmune disorders in children can cause symptoms often mistaken for common childhood illnesses. More precise diagnoses and ...

Dermatomyositis and lupus may share symptoms in some cases. Here's what you need to know about these autoimmune conditions.

Conduit Pharmaceuticals partners with Charles River to evaluate the efficacy of its lead programme in a pre-clinical lupus model, utilizing ...

Children with lupus nephritis who receive ... and cyclophosphamide for the treatment of renal involvement in systemic lupus erythematosus, according to observational data published in BMC ...

Interferon-alpha activity may be used routinely in clinical settings as a biomarker for cutaneous lupus erythematosus and ...